scholarly journals RANOLAZINE AT THE END OF TRASTUZUMAB THERAPY PREVENTS LEFT VENTRICULAR DYSFUNCTION: IN VITRO AND IN VIVO STUDY

2016 ◽  
Vol 67 (13) ◽  
pp. 1354
Author(s):  
Nicola Maurea ◽  
Carmela Coppola ◽  
Giovanna Piscopo ◽  
Domenica Rea ◽  
Gennaro Riccio ◽  
...  
Keyword(s):  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
In Vivo Study ◽  
Trastuzumab Therapy

scholarly journals 1116-11 The mineralocorticoid paradox: Profibrotic in vivo in experimental asymptomatic left ventricular dysfunction but antifibrotic in vitro

2004 ◽  
Vol 43 (5) ◽  
pp. A22
Author(s):  
Lisa C Costello-Boerrigter ◽  
Guido Boerrigter ◽  
Gail J Harty ◽  
Alessandro Cataliotti ◽  
Denise M Heublein ◽  
...  
Keyword(s):  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular

Left ventricular dysfunction is associated with cerebral grey matter injury: An in-vivo brain MRI segmentation study

2012 ◽  
Vol 321 (1-2) ◽  
pp. 111-113 ◽  
Author(s):  
Pratik Bhattacharya ◽  
Fen Bao ◽  
Megha Shah ◽  
Gautam Ramesh ◽  
Ramesh Madhavan ◽  
...  
Keyword(s):  
Left Ventricular Dysfunction ◽  
Grey Matter ◽  
Ventricular Dysfunction ◽  
Brain Mri ◽  
Left Ventricular ◽  
Mri Segmentation ◽  
Cerebral Grey Matter ◽  
Grey Matter Injury

scholarly journals SOCS1/JAB Likely Mediates the Protective Effect of Cardiotrophin-1 Against Lipopolysaccharide-Induced Left Ventricular Dysfunction In Vivo

2005 ◽  
Vol 69 (11) ◽  
pp. 1412-1417 ◽  
Author(s):  
Keiji Tanimoto ◽  
Yoshihiko Saito ◽  
Ichiro Hamanaka ◽  
Koichiro Kuwahara ◽  
Masaki Harada ◽  
...  
Keyword(s):  
Protective Effect ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular

Cardiac safety of continuous trastuzumab therapy in breast cancer patients with asymptomatic left ventricular dysfunction.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. e11602-e11602
Author(s):  
Anthony Francis Yu ◽  
Nandini U Yadav ◽  
Anne Eaton ◽  
Betty Y Lung ◽  
Howard T. Thaler ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Breast Cancer Patients ◽  
Cardiac Safety ◽  
Trastuzumab Therapy

scholarly journals Continuous Trastuzumab Therapy in Breast Cancer Patients With Asymptomatic Left Ventricular Dysfunction

2015 ◽  
Vol 20 (10) ◽  
pp. 1105-1110 ◽  
Author(s):  
Anthony F. Yu ◽  
Nandini U. Yadav ◽  
Anne A. Eaton ◽  
Betty Y. Lung ◽  
Howard T. Thaler ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
Breast Cancer Patients ◽  
Trastuzumab Therapy

Assessment of the stability of N-terminal pro-brain natriuretic peptide in vitro: implications for assessment of left ventricular dysfunction

1999 ◽  
Vol 97 (3) ◽  
pp. 255 ◽  
Author(s):  
P.F. DOWNIE ◽  
S. TALWAR ◽  
I.B. SQUIRE ◽  
J.E. DAVIES ◽  
D.B. BARNETT ◽  
...  
Keyword(s):  
Brain Natriuretic Peptide ◽  
Natriuretic Peptide ◽  
Left Ventricular Dysfunction ◽  
Ventricular Dysfunction ◽  
Left Ventricular ◽  
The Stability

2-D Left Ventricular Flow Estimation by Combining Speckle Tracking With Navier–Stokes-Based Regularization: An In Silico, In Vitro and In Vivo Study

2015 ◽  
Vol 41 (1) ◽  
pp. 99-113 ◽  
Author(s):  
Hang Gao ◽  
Nathalie Bijnens ◽  
Damien Coisne ◽  
Mathieu Lugiez ◽  
Marcel Rutten ◽  
...  
Keyword(s):  
In Silico ◽  
Speckle Tracking ◽  
Left Ventricular ◽  
In Vivo Study ◽  
Navier Stokes ◽  
Flow Estimation
Sign in / Sign up

Export Citation Format

Share Document